HomeNews

News

A New Therapeutic Strategy Could Make Waves in Kidney Most cancers Remedy

On the 2025 ASCO Annual Assembly, key updates within the therapy of assorted cancers have been shared with physicians and sufferers, together with...

Rusfertide Reduces Phlebotomy Want, Improves High quality of Life in Polycythemia Vera

Rusfertide decreased phlebotomy want and improved high quality of life in sufferers with polycythemia vera, based on part 3 VERIFY trial outcomes.Remedy with...

Being a Most cancers Survivor is a Reward I By no means Take for Granted

Kelly Irvin was identified with stage 4 ovarian most cancers in January 2016. Make amends for all of Kelly's blogs right here!It’s Nationwide Most...

What Sufferers With Genitourinary Cancers Ought to Know After ASCO 2025

Dr. Joshua Okay. Sabari sat down with Dr. Daniel V. Araujo to debate topline takeaways from the 2025 ASCO Annual Assembly throughout the...

FDA Approves Ibtrozi for ROS1+ Superior Non-Small Cell Lung Most cancers

The FDA has authorised Ibtrozi for sufferers with domestically superior or metastatic ROS1+ NSCLC.The U.S. Meals and Drug Administration had authorised Ibtrozi (taletrectinib)...

Hot Topics